Skip to main content
Premium Trial:

Request an Annual Quote

NEWSBRIEF: Caliper CEO Kisner Steps Down, Replaced by Company Co-founder

SAN FRANCISCO, May 13 - Caliper Technologies named Michael Knapp to replace Daniel Kisner as CEO, the company said today.


Knapp, a Caliper founder and vice president of corporate development, will step into the CEO position as of July 1, when Kisner will become chairman of the board, according the company.


Kisner also will relinquish his responsibilities as president, which will be filled by James Knighton, who will also serve in his current role as chief financial officer of the company.


A company spokesperson said the moves did not signal a change in Caliper's business plan and was intended to allow Kisner to "balance professional and family needs."


Kisner will be on site at the company's Mountain View, Calif.headquarters one or two days per week as chairman, according to the spokesperson.


David Milligan, Caliper's current chairman, will become vice chairman.


Click here for more information.


The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.